Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ICON plc - Ordinary Shares (NQ:ICLR)

190.25 -2.06 (-1.07%)
Streaming Delayed Price Updated: 12:14 PM EDT, Oct 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ICON plc - Ordinary Shares

< Previous 1 2 3 4 5 Next >
ICON PLC (NASDAQ:ICLR): A Value Investing Case Study
ICON PLC (ICLR) presents a strong value investing case with attractive P/E ratios, solid profitability, and stable financial health, suggesting potential undervaluation. 
Via Chartmill
11 Analysts Assess Icon: What You Need To Know
 
Via Benzinga
3 Healthcare Pathbreakers With Long-Term Tailwinds
These three firms in the fast-changing healthcare sector stand out to analysts for their strong product lineups, defensible technology, and notable pipelines. 
Via MarketBeat
Assessing Icon: Insights From 8 Financial Analysts
 
Via Benzinga
ICON PLC (NASDAQ:ICLR) Presents a Compelling Value Investment Opportunity with Strong Fundamentals
ICON PLC (ICLR) is a value stock with strong valuation metrics, solid profitability, and stable financials, trading below industry averages. A potential undervalued opportunity for investors. 
Via Chartmill
Earnings Scheduled For July 23, 2025
 
Via Benzinga
Insights Ahead: Icon's Quarterly Earnings
 
Via Benzinga
Earnings Scheduled For April 30, 2025
 
Via Benzinga
Earnings Scheduled For February 19, 2025
 
Via Benzinga
NASDAQ:ICLR is an undervalued gem with solid fundamentals.
When you look at ICON PLC (NASDAQ:ICLR), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. 
Via Chartmill
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio?
Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance. 
Via Benzinga
Topics Earnings
ICON Stock Up After Q2 Results Signal Growing Confidence In Biopharma Recovery
ICON lifts its 2025 revenue forecast, beats booking targets in Q2 and expands its share buyback plan as market conditions remain variable. 
Via Benzinga
RPM International Posts Better-Than-Expected Earnings, Joins ICON, MaxLinear, Nasdaq And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Thursday's session: gap up and gap down stocks
Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
This Spotify Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
 
Via Benzinga
Why Alphabet Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
ICON PLC (NASDAQ:ICLR) Reports Q2 2025 Earnings Slightly Below Estimates, Shares Surge 13.76% in After-Hours Trading
ICON PLC (ICLR) reported Q2 2025 earnings slightly below estimates but saw a 13.76% stock surge. Revenue hit $2.02B, EPS $3.26. AGM resolutions passed, boosting investor confidence. 
Via Chartmill
Wednesday's after hours session: top gainers and losers
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
ICON PLC (NASDAQ:ICLR) – A Potentially Undervalued Stock in the Life Sciences Sector
ICON PLC (NASDAQ:ICLR) appears undervalued with strong profitability and reasonable financial health, making it a potential candidate for value investors in the life sciences sector. 
Via Chartmill
LVM Capital Management Dumps 16,000 ICON Public Shares Worth $2.6 million
Via The Motley Fool
Topics Regulatory Compliance
Get insights into the top gainers and losers of Wednesday's after-hours session.
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
This Saia Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday
 
Via Benzinga
ICON PLC (NASDAQ:ICLR): good value for what you're paying.
Discover ICON PLC, an undervalued stock. NASDAQ:ICLR showcases solid financial health and profitability while maintaining an appealing valuation. 
Via Chartmill
Elliott Investment Management Buys Wolfspeed Stock, Bets Against Nvidia In Q4
Elliott Investment Management made several portfolio moves in the fourth quarter, closing multiple options positions and shaking up the activist firm's technology exposure. 
Via Benzinga
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX,... 
Via Benzinga
Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty
ICON forecasts 2025 revenue at $8.05 billion–$8.65 billion and adjusted EPS of $13.00–$15.00, citing biopharma spending cuts and biotech recovery delays. 
Via Benzinga
This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
 
Via Benzinga
NASDAQ:ICLR is an undervalued gem with solid fundamentals.
For those who appreciate value investing, ICON PLC (NASDAQ:ICLR) is a compelling option with its solid fundamentals. 
Via Chartmill
13 Healthcare Sector Stocks With Healthy Valuation
We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty... 
Via Talk Markets
Topics Stocks Stocks / Equities
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.